SHL Telemedicine Ltd.
OTC: SMDCF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Medical - Healthcare Information Services
- CEO
- Erez Nachtomy
- Employees
- 402
- Headquarters
- Tel Aviv, Israel
- IPO year
- 2016
- Market cap
- $280.9M
- Website
- https://www.shl-telemedicine.com
Loading SMDCF…
Loading profile data…Frequently asked questions about SMDCF
What does SHL Telemedicine Ltd. (SMDCF) do?
SHL Telemedicine Ltd., an Israeli company, develops and globally markets a range of personal telemedicine solutions across Israel, Europe, and other international territories. The firm specializes in cardiac monitoring devices, offering products such as SmartHeart, a mobile 12-lead ECG instrumental in detecting heart attacks, alongside the Cardi...
Where does SMDCF trade?
SHL Telemedicine Ltd. (SMDCF) trades on the Other OTC.
What sector is SMDCF in?
SHL Telemedicine Ltd. (SMDCF) operates in the Healthcare sector, specifically in the Medical - Healthcare Information Services industry.
Who is the CEO of SHL Telemedicine Ltd.?
Erez Nachtomy is the chief executive officer of SHL Telemedicine Ltd. (SMDCF).
Where is SHL Telemedicine Ltd. headquartered?
SHL Telemedicine Ltd. is headquartered in Israel.
Does SMDCF pay a dividend?
Yes — SHL Telemedicine Ltd. (SMDCF) paid a trailing twelve-month dividend of USD 1.00 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did SMDCF go public?
SHL Telemedicine Ltd. (SMDCF) completed its initial public offering in 2016.